Skip to main content
. 2016 Aug 5;8(39):64954–64963. doi: 10.18632/oncotarget.11066

Table 1. Baseline clinicopathologic features of liver cancer patients in SEER database.

Characteristic Total
(%)
Married
(%)
Divorced/ Separated(%) Widowed
(%)
Single
(%)
P value
40809 (100) 21939 (53.8) 5871 (14.4) 4339 (10.6) 8660 (21.2)
Gender
 Male 30456 (74.6) 17474 (79.6) 4496 (76.6) 1631 (37.6) 6855 (79.2) < 0.001
 Female 10353 (25.4) 4465 (20.4) 1375 (23.4) 2708 (62.4) 1805 (20.8)
Age
 ≤ 60 19203 (47.1) 9704 (44.2) 3309 (56.4) 519 (12.0) 5671 (65.5) < 0.001
 > 60 21606 (52.9) 12235 (55.8) 2562 (43.6) 3820 (88.0) 2989 (34.5)
Race
 White 27753 (68) 14767 (67.3) 4282 (72.9) 3050 (70.3) 5654 (65.3) < 0.001
 Black 5323 (13.0) 1862 (8.5) 970 (16.5) 464 (10.7) 2027 (23.4)
 Asian/Pacific Islander 7093 (17.4) 5022 (22.9) 490 (8.3) 759(17.5) 822 (9.5)
 American Indian/Alaska
 Native
479 (1.2) 202 (0.9) 105 (1.8) 49 (1.1) 123 (1.4)
 Unknown 161 (0.4) 86 (0.4) 24 (0.4) 17 (0.4) 34 (0.4)
Grade < 0.001
 High/Moderate 10856 (26.6) 6320 (28.8) 1418 (24.2) 1093(25.2) 2025 (23.4)
 Poor/Undifferentiation 4080 (10%) 2392 (10.9) 537 (9.1) 442 (10.2) 709 (8.2)
 Unknown 25873 (63.4) 13227 (60.3) 3916 (66.7) 2804 (64.6) 5926 (68.4)
Histotype < 0.001
 Hepatocellular carcinoma 36397 (89.2) 19347 (88.2) 5403 (92.0) 3622 (83.5) 8025 (92.7)
 Cholangiocarcinoma 4102 (10.1) 2403 (11.0) 428 (7.3) 688 (15.9) 583 (6.7)
 Combined 310 (0.8) 189 (0.9) 40 (0.7) 29 (0.7) 52 (0.6)
SEER stage < 0.001
 Localized 18618 (45.6) 10194 (46.5) 2763 (47.1) 1910 (44.0) 3751 (43.3)
 Regional 11908 (29.2) 6418 (29.3) 1702 (29.0) 1160 (26.7) 2628 (30.3)
 Distant 7083 (17.4) 3721(17.0) 974 (16.6) 757 (17.4) 1631 (18.8)
 Unstaged 3200 (7.8) 1606 (7.3) 432 (7.4) 512 (11.8) 650 (7.5)
Therapy < 0.001
 Surgery, radiation or both 11702 (28.7) 7278 (33.2) 1528 (26.0) 872 (20.1) 2024 (23.4)
 No surgery, radiation 28422 (69.6) 14311 (65.2) 4223 (71.9) 3384 (78.0) 6504 (75.1)
 Unknown 685 (1.7) 350 (1.6) 120 (2.0) 83 (12.1) 132 (1.5)

Abbreviations

SEER, Surveillance, Epidemiology and End Results.